(VIANEWS) – Shares of Catalyst Pharmaceuticals (NASDAQ Composite: CPRX) rose 8.07% to $5.43 at 12:20 EST on Thursday, after four sequential sessions in a row of gains. NASDAQ Composite is rising 0.39% to $14,568.98, after five consecutive sessions in a row of losses. This seems, as yet, a somewhat bullish trend trading session today.

Catalyst Pharmaceuticals’s last close was $5.08, 18.59% below its 52-week high of $6.24.


Today’s last reported volume for Catalyst Pharmaceuticals is 1312005 which is 68.53% above its average volume of 778479.

Catalyst Pharmaceuticals’s Sales

Catalyst Pharmaceuticals’s sales growth is 18% for the ongoing quarter and 15.6% for the next.

Catalyst Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth grew by 22.8%, now sitting on 126.9M for the twelve trailing months.


Catalyst Pharmaceuticals’s last week, last month’s, and last quarter’s current volatility was a positive 0.59%, a negative 0.47%, and a positive 1.75%, respectively.

Catalyst Pharmaceuticals’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.59% (last week), 1.68% (last month), and 1.75% (last quarter), respectively.

Catalyst Pharmaceuticals’s Stock Yearly Top and Bottom Value

Catalyst Pharmaceuticals’s stock is valued at $5.43 at 12:20 EST, way under its 52-week high of $6.24 and way higher than its 52-week low of $2.88.

Catalyst Pharmaceuticals’s Moving Average

Catalyst Pharmaceuticals’s value is higher than its 50-day moving average of $5.32 and higher than its 200-day moving average of $5.23.

More news about Catalyst Pharmaceuticals (CPRX).


Please enter your comment!
Please enter your name here